首页 › 基金 › Per Stirling Capital Management, LLC. › DOCT
Per Stirling Capital Management, LLC. 对 DOCT 的持仓历史
FIRST TR EXCHNG TRADED FD VI
Per Stirling Capital Management, LLC. 在 Q3 2026 的 13F 申报中披露持有 DOCT(FIRST TR EXCHNG TRADED FD VI)143,057 股,市值约 US$6.9M,约占其申报组合的 0.66%,在其申报持仓中市值排名第 44 位。 Per Stirling Capital Management, LLC. 最近 13 个申报季度中有 13 个季度披露了 DOCT 持仓,最早可追溯至 Q3 2023。
最后更新: 2026-11-13 · 来源: SEC EDGAR Form 13F-HR
Per Stirling Capital Management, LLC. 对 DOCT 的持仓演变
Per Stirling Capital Management, LLC. 于 Q3 2023 首次披露 DOCT 持仓:68,818 股(约 US$2.4M)。 该持仓在 Q3 2024 达到峰值 209,918 股,市值约 US$8.2M。 在 13 次申报中,Per Stirling Capital Management, LLC. 6 次增持、4 次减持、2 次保持不变。 最近一期申报(Q3 2026)显示持股 143,057 股、市值约 US$6.9M。 持仓曾出现大幅变动:Q4 2023 增持约 211% (随后一个季度股价上涨 6%)、Q1 2025 减持约 34% (随后一个季度股价上涨 7%)。
逐季持仓明细
| 季度 | 股数 | 金额 | 变化 |
|---|---|---|---|
| Q3 2023 | 68.82K | $2.38M | 新进 |
| Q4 2023 | 213.99K | $7.78M | 增持 |
| Q1 2024 | 215.20K | $8.10M | 增持 |
| Q2 2024 | 209.70K | $8.05M | 减持 |
| Q3 2024 | 209.92K | $8.19M | 持有 |
| Q4 2024 | 204.01K | $8.03M | 减持 |
| Q1 2025 | 134.98K | $5.18M | 减持 |
| Q2 2025 | 136.19K | $5.59M | 增持 |
| Q3 2025 | 137.65K | $5.95M | 增持 |
| Q4 2025 | 133.89K | $5.93M | 减持 |
| Q1 2026 | 136.13K | $5.91M | 增持 |
| Q2 2026 | 143.12K | $6.68M | 增持 |
| Q3 2026 | 143.06K | $6.87M | 持有 |
折线上的点按变动类型着色;缺失季度表示该季未申报持仓。
关于 DOCT 与 13F 数据
DOCT(FIRST TR EXCHNG TRADED FD VI)的行业分类暂缺。我们追踪的基金中还有 31 只申报持有 DOCT,申报仓位最大的包括:OGOREK ANTHONY JOSEPH /NY/ /ADV (US$13.6M), REAP Financial Group, LLC (US$9.8M), Wood Tarver Financial Group, LLC (US$8.3M)。 根据美国 SEC 规定,管理资产超过 1 亿美元的机构投资者须在每季度结束后 45 天内提交 13F 表,披露其美股多头持仓。该数据不包含空头、大部分期权及海外持仓,因此应将其视为季度快照而非实时仓位。
其它持有 DOCT 的基金
- OGOREK ANTHONY JOSEPH /NY/ /ADV 283.36K 股 · $13.61M · Q3 2026
- REAP Financial Group, LLC 203.71K 股 · $9.79M · Q3 2026
- Wood Tarver Financial Group, LLC 176.85K 股 · $8.26M · Q2 2026
- LCNB CORP 114.17K 股 · $5.49M · Q3 2026
- WINNACLE WEALTH LLC 96.05K 股 · $4.61M · Q3 2026
- Foguth Wealth Management, LLC. 87.03K 股 · $4.20M · Q3 2026
- Commonwealth Financial Services, LLC 46.50K 股 · $2.23M · Q3 2026
- Castleview Partners, LLC 32.36K 股 · $1.55M · Q3 2026
更多关于 Per Stirling Capital Management, LLC.
常见问题
How long has Per Stirling Capital Management, LLC. held DOCT?
Per Stirling Capital Management, LLC. has disclosed DOCT holdings in 13 of the last 13 reported quarters, going back to Q3 2023.
What is Per Stirling Capital Management, LLC.'s current position in DOCT?
As of Q3 2026, Per Stirling Capital Management, LLC. holds 143.06K shares of DOCT (FIRST TR EXCHNG TRADED FD VI), valued at $6.87M, representing 0.66% of its reported portfolio and ranking #44.
Has Per Stirling Capital Management, LLC. been buying or selling DOCT?
In the latest 13F filing (Q3 2026), Per Stirling Capital Management, LLC. held unchanged its position in DOCT. The position peaked in Q3 2024 at 209.92K shares.
Which other funds hold DOCT?
Other major institutional holders of DOCT include OGOREK ANTHONY JOSEPH /NY/ /ADV, REAP Financial Group, LLC, Wood Tarver Financial Group, LLC, among 31 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.